Boothbay Fund Management’s Integra LifeSciences IART Stock Holding History

Boothbay Fund Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,300	Closed	-$508K	–	1794
2023 Q3	$508K	Buy	13,300 +8,000	+151%	+$337K	0.01%	1027
2023 Q2	$218K	Buy	+5,300	New	+$255K	﹤0.01%	1448
2023 Q1	–	Sell	-5,700	Closed	-$320K	–	2307
2022 Q4	$320K	Buy	+5,700	New	+$290K	0.01%	1362

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boothbay Fund Management's IART Position: Q1 2026 in Review

Boothbay Fund Management sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 26,881 shares — an estimated $334K sold.

Boothbay Fund Management first reported a position in IART in Q3 2022 and held it in 2 quarters. The position peaked at $334K in Q4 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Boothbay Fund Management reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
Boothbay Fund Management sold 26,881 Integra LifeSciences shares in Q1 2026, an estimated $334K.
Boothbay Fund Management first reported a position in Integra LifeSciences in Q3 2022 and held it in 2 quarters.
Boothbay Fund Management's Integra LifeSciences position peaked at $334K in Q4 2025.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.